Semaglutide acetate is a long-acting, selective GLP-1R agonist that penetrates the blood-brain barrier. It promotes insulin secretion, inhibits gastric emptying, and regulates lipid metabolism. This compound aids in lowering blood sugar, reducing weight, and improving hepatic steatosis. It is primarily researched for neurodegenerative diseases, type 2 diabetes, obesity, Parkinson's disease, and metabolic associated fatty liver disease (MASLD).
- Long-acting, selective GLP-1R agonist
- Penetrates blood-brain barrier
- Promotes insulin secretion, inhibits gastric emptying
- Enhances autophagy, inhibits apoptosis
- Regulates lipid metabolism, lowers blood sugar
- Reduces weight, improves hepatic steatosis
- Provides neuroprotection
- Researched for diabetes, obesity, Parkinson's disease, MASLD
- Anti-tumor and anti-proliferation activity